Aflibercept OverviewAflibercept is a biopharmaceutical drug invented by Regeneron Pharmaceuticals, approved in the United States and Europe for the treatment of wet macular degeneration under the trade name Eylea, and for metastatic colorectal cancer as Zaltrap. As the active ingredient of Zaltrap, the substance is called ziv-aflibercept in the US. It is an inhibitor of vascular endothelial growth factor (VEGF). Aflibercept is being co-developed for cancer treatment by San...
Read more Aflibercept Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Aflibercept
Recent Aflibercept Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 40mg/ml